Zoli M - Search Results

1

Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors.

Pucci S, Fasoli F, Moretti M, Benfante R, Di Lascio S, Viani P, Daga A, Gordon TJ, McIntosh M, Zoli M, Clementi F, Gotti C. Pucci S, et al. Among authors: zoli m. Pharmacol Res. 2021 Jan;163:105336. doi: 10.1016/j.phrs.2020.105336. Epub 2020 Dec 1. Pharmacol Res. 2021. PMID: 33276105 Free article.

2

Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

Gotti C, Zoli M, Clementi F. Gotti C, et al. Among authors: zoli m. Trends Pharmacol Sci. 2006 Sep;27(9):482-91. doi: 10.1016/j.tips.2006.07.004. Epub 2006 Jul 31. Trends Pharmacol Sci. 2006. PMID: 16876883 Review.

3

Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner.

Pistillo F, Fasoli F, Moretti M, McClure-Begley T, Zoli M, Marks MJ, Gotti C. Pistillo F, et al. Among authors: zoli m. Pharmacol Res. 2016 Jan;103:167-76. doi: 10.1016/j.phrs.2015.11.016. Epub 2015 Nov 26. Pharmacol Res. 2016. PMID: 26631628

4

Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.

Zoli M, Pucci S, Vilella A, Gotti C. Zoli M, et al. Curr Neuropharmacol. 2018;16(4):338-349. doi: 10.2174/1570159X15666170912110450. Curr Neuropharmacol. 2018. PMID: 28901280 Free PMC article. Review.

5

Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9-nicotinic ligands on glioblastoma cells.

Pucci S, Bolchi C, Bavo F, Pallavicini M, De Palma C, Renzi M, Fucile S, Benfante R, Di Lascio S, Lattuada D, Bessereau JL, D'Alessandro M, Risson V, Zoli M, Clementi F, Gotti C. Pucci S, et al. Among authors: zoli m. Pharmacol Res. 2022 Jan;175:105959. doi: 10.1016/j.phrs.2021.105959. Epub 2021 Oct 28. Pharmacol Res. 2022. PMID: 34756924 Free article.

6

α9-Containing Nicotinic Receptors in Cancer.

Pucci S, Zoli M, Clementi F, Gotti C. Pucci S, et al. Among authors: zoli m. Front Cell Neurosci. 2022 Jan 21;15:805123. doi: 10.3389/fncel.2021.805123. eCollection 2021. Front Cell Neurosci. 2022. PMID: 35126059 Free PMC article. Review.

7

In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of α4β2 nicotinic receptors in cortex and thalamus.

Fasoli F, Moretti M, Zoli M, Pistillo F, Crespi A, Clementi F, Mc Clure-Begley T, Marks MJ, Gotti C. Fasoli F, et al. Among authors: zoli m. Neuropharmacology. 2016 Sep;108:324-31. doi: 10.1016/j.neuropharm.2016.04.048. Epub 2016 May 6. Neuropharmacology. 2016. PMID: 27157710

8

Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.

Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C. Zoli M, et al. J Neurosci. 2002 Oct 15;22(20):8785-9. doi: 10.1523/JNEUROSCI.22-20-08785.2002. J Neurosci. 2002. PMID: 12388584 Free PMC article.

9

Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience.

Moretti M, Vailati S, Zoli M, Lippi G, Riganti L, Longhi R, Viegi A, Clementi F, Gotti C. Moretti M, et al. Among authors: zoli m. Mol Pharmacol. 2004 Jul;66(1):85-96. doi: 10.1124/mol.66.1.85. Mol Pharmacol. 2004. PMID: 15213299

10

Heterogeneity and complexity of native brain nicotinic receptors.

Gotti C, Moretti M, Gaimarri A, Zanardi A, Clementi F, Zoli M. Gotti C, et al. Among authors: zoli m. Biochem Pharmacol. 2007 Oct 15;74(8):1102-11. doi: 10.1016/j.bcp.2007.05.023. Epub 2007 Jun 2. Biochem Pharmacol. 2007. PMID: 17597586 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

717 results

Search Page

Filters